Retrospective evaluation of the pharmaceutical pathway for prophylactic use of antibiotics during the perioperative period of class Ⅰ neurosurgery incisions

WANG Jinping; ZHAO Jie; YANG Chunyan; LAI Xiaomin; ZHU Yunteng; WU Zhi’ang

doi:10.6039/j.issn.1001-0408.2024.17.16

您当前的位置：

首页 >

文章列表页 >

Retrospective evaluation of the pharmaceutical pathway for prophylactic use of antibiotics during the perioperative period of class Ⅰ neurosurgery incisions

更新时间：2024-09-09

- Retrospective evaluation of the pharmaceutical pathway for prophylactic use of antibiotics during the perioperative period of class Ⅰ neurosurgery incisions
- ZHONGGUO YAOFANG Vol. 35, Issue 17, Pages: 2147-2151(2024)
- 作者机构：
  
  1.沈阳药科大学工商管理学院，沈阳　110016
  2.深圳市第二人民医院药学部，广东深圳　518035
  3.广西中医药大学研究生院，南宁　530000
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2024.17.16
  CLC： R95;R978.1
- Published：15 September 2024，
  
  Received：28 May 2024，
  
  Revised：14 June 2024，
- 稿件说明：
移动端阅览
王金平,赵婕,杨春燕等.神经外科Ⅰ类切口围手术期抗菌药物预防使用药学路径的回顾性评价 ^Δ[J].中国药房,2024,35(17):2147-2151.

WANG Jinping,ZHAO Jie,YANG Chunyan,et al.Retrospective evaluation of the pharmaceutical pathway for prophylactic use of antibiotics during the perioperative period of class Ⅰ neurosurgery incisions[J].ZHONGGUO YAOFANG,2024,35(17):2147-2151.
王金平,赵婕,杨春燕等.神经外科Ⅰ类切口围手术期抗菌药物预防使用药学路径的回顾性评价 ^Δ[J].中国药房,2024,35(17):2147-2151. DOI： 10.6039/j.issn.1001-0408.2024.17.16.

WANG Jinping,ZHAO Jie,YANG Chunyan,et al.Retrospective evaluation of the pharmaceutical pathway for prophylactic use of antibiotics during the perioperative period of class Ⅰ neurosurgery incisions[J].ZHONGGUO YAOFANG,2024,35(17):2147-2151. DOI： 10.6039/j.issn.1001-0408.2024.17.16.

摘要

目的

探讨神经外科Ⅰ类切口手术患者围手术期预防使用抗菌药物药学路径的可行性。

方法

运用前期建立的神经外科Ⅰ类切口手术患者围手术期预防使用抗菌药物药学路径，回顾性评估127例神经外科Ⅰ类切口手术患者围手术期预防使用抗菌药物的情况，运用药学路径中“抗菌药物预防使用评分体系”进行术前评分，并与患者实际用药情况比较，结合现有《抗菌药物临床应用指导原则（2015版）》（以下简称为《指导原则》）进行分析。对于术中抗菌药物追加次数及术后抗菌药物预防使用时间，药学路径也创新性提出可改进的关键点，通过与患者实际的用药情况进行了对比，探讨《指导原则》可尝试更新的方向。

结果

依据回顾性分析结果，神经外科Ⅰ类切口手术中除了《指导原则》已建议的不推荐颅骨肿物切除术和颈动脉内膜切除术患者术前预防使用抗菌药物外，内镜下三叉神经微血管减压术、关节镜其他特指关节检查、脊神经根减压术、内镜下腰椎髓核切除术、硬脊膜修补术、椎管减压术手术也可进一步探索术前不预防性使用抗菌药物；同时，对于神经外科Ⅰ类切口手术患者术中、术后抗菌药物的使用，结合手术时间术中可考虑进行第2次追加抗菌药物，手术患者如出现脑脊液漏，建议可适当延长抗菌药物预防使用时间。

结论

药学路径的应用可更有针对性地分析抗菌药物预防使用的关键点，推动了Ⅰ类切口围手术期抗菌药物管理方式从“定性、经验”的管理向“定量、科学”的管理转型。

Abstract

OBJECTIVE

To explore the practicality of the pharmaceutical pathway for prophylactic use of antibiotics during the perioperative period of class Ⅰ neurosurgery incisions.

METHODS

The previously established pharmaceutical pathway for the prophylactic use of antibiotics in the perioperative period of class Ⅰ neurosurgery incisions was used to retrospectively evaluate the prophylactic use of antibiotics in 127 cases. The “antibiotics prophylactic use scoring system” in the pharmaceutical pathway was used to conduct preoperative scoring， and the patient’s actual antibiotics use was compared and analyzed in combination with existing

Guiding Principles for Clinical Application of Antibiotics

（2015 Edition）（hereinafter referred to as the

Guiding Principles

）. The pharmaceutical pathway also innovatively proposes key points for improvement in terms of the frequency of adding antibiotics during surgery and the duration of prophylactic use of antibiotics after surgery. By co

mparing with the actual medication situation of patients， the direction for updating the

Guiding Principles

was explored.

RESULTS

According to the retrospective analysis results， for neurosurgery class Ⅰ incision surgery， in addition to the preoperative prophylactic use of antibacterial drugs for skull mass resection and carotid endarterectomy recommended in the guidelines， endoscopic trigeminal microvascular decompression， arthroscopy and other specific joint examinations， spinal nerve Radical decompression， endoscopic lumbar nucleectomy， dural repair， and spinal canal decompression can also be further explored about the situation of not using antibacterial prophylaxis before surgery； at the same time， for the patients undergoing class Ⅰ neurosurgery incisions， the use of antibiotics during and after surgery may be considered for a second addition of antibiotics， taking into account the surgical time. If cerebrospinal fluid leakage occurred after surgery， it is recommended to extend the duration of prophylactic use of antibiotics appropriately.

CONCLUSIONS

The application of pharmaceutical pathways can provide more targeted analysis of key points in the prevention of antibiotic use， which promotes the transformation of perioperative antibiotics management for class Ⅰ incisions from “qualitative， empirical” management to “quantitative， scientific” management.

关键词

药学路径神经外科Ⅰ类切口抗菌药物预防用药

Keywords

neurosurgeryclass Ⅰ incisionsantibioticsprophylactic use of drugs

references

FUGLESTAD M A，TRACEY E L，LEINICKE J A. Evidence-based prevention of surgical site infection[J]. Surg Clin North Am，2021，101（6）：951-966.

LEAPER D，OUSEY K. Evidence update on prevention of surgical site infection[J]. Curr Opin Infect Dis，2015，28（2）：158-163.

MCFARLAND A M，MANOUKIAN S，MASON H，et al. Impact of surgical-site infection on health utility values：a meta-analysis[J]. Br J Surg，2023，110（8）：942-949.

TURNER M C，MIGALY J. Surgical site infection：the clinical and economic impact[J]. Clin Colon Rectal Surg，2019，32（3）：157-165.

GARNER B H，ANDERSON D J. Surgical site infections：an update[J]. Infect Dis Clin North Am，2016，30（4）：909-929.

抗菌药物临床应用指导原则修订工作组.抗菌药物临床应用指导原则：2015年版[M].北京：人民卫生出版社，2015：1-87.

Revision Working Group on Guidelines for Clinical Application of Antibiotics. Guidelines for clinical application of antibiotics：2015 edition[M]. Beijing：People’s Health Publishing House，2015：1-87.

国家卫健委抗菌药物临床应用监测网. 2022年全国医院抗菌药物临床应用监测数据[EB/OL].[2024-05-06]. http：//y.chinadtc.org.cn/loginhttp://y.chinadtc.org.cn/login.

Clinical Application Monitoring Network of Antibiotics by the National Health Commission. Clinical application monitoring data of antibiotics in national hospitals in 2022[EB/OL].[2024-05-06]. http：//y.chinadtc.org.cn/loginhttp://y.chinadtc.org.cn/login.

李恒爱，刘大钺，卢建军，等. 神经外科Ⅰ类切口术后感染影响因素分析[J]. 中华医院感染学杂志，2017，27（17）：3940-3943.

LI H A，LIU D Y，LU J J，et al. Analysis of influencing factors of postoperative infections of type Ⅰ incision in neurosurgery[J]. Chin J Nosocomiology，2017，27（17）：3940-3943.

STASZEWICZ W，EISENRING M C，BETTSCHART V，et al. Thirteen years of surgical site infection surveillance in Swiss hospitals[J]. J Hosp Infect，2014，88（1）：40-47.

徐廷伟，敖祥生，秦永芳，等. 神经外科患者术后颅内感染危险因素分析[J]. 中华医院感染学杂志，2016，26（8）：1758-1760.

XU T W，AO X S，QIN Y F，et al. Risk factors of intracranial infection after operation in department of neurosurgery[J]. Chin J Nosocomiology，2016，26（8）：1758-1760.

郑国寿，占成业，高伟，等. 普外科急诊手术切口裂开相关因素的Logistic回归分析[J]. 中国现代普通外科进展，2014，17（10）：806-808.

ZHENG G S，ZHAN C Y，GAO W，et al. Logistic regression analysis of related factors of incision dehiscence in general surgery emergency operation[J]. Chin J Curr Adv Gen Surg，2014，17（10）：806-808.

叶燕婷. 普外科手术部位感染的Logistic回归分析[J]. 护理实践与研究，2013，10（14）：5-7.

YE Y T. Logistic regression analysis of operation site infection in general surgical[J]. Nurs Pract Res，2013，10（14）：5-7.

惠亚，顾成武，江冬萍，等. Logistic回归和分类树模型探讨颅脑手术后颅内感染相关因素及其交互作用[J]. 现代医药卫生，2019，35（4）：567-570.

HUI Y，GU C W，JIANG D P，et al. Logistic regression and classification tree model to explore the related factors and their interaction of intracranial infection after craniocerebral operation[J]. J Mod Med Health，2019，35（4）：567-570.

王基云，王丹，张彦杰，等. 15 389例Ⅰ类切口手术及血管介入操作围手术期预防性应用抗菌药物调查与分析[J]. 中国医院用药评价与分析，2020，20（10）：1244-1248.

WANG J Y，WANG D，ZHANG Y J，et al. Investigation and analysis of perioperative prophylactic application of antibiotics in 15 389 cases of type Ⅰ incision and vascular intervention surgery[J]. Eval Anal Drug Use Hosp China，2020，20（10）：1244-1248.

郭宝均. Ⅰ类切口手术抗菌药物合理预防性应用调查分析[J]. 中外医疗，2016，35（12）：38-40.

GUO B J. Survey analysis of rational predictive application of antibacterials in type Ⅰ incision operation[J]. China Foreign Med Treat，2016，35（12）：38-40.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

我院3 种清洁手术患者预防用抗菌药物干预研究

3 个阶段心血管介入诊疗手术预防用抗菌药物干预分析

专项整治前后某三级甲等医院Ⅰ类切口手术患者围术期预防用抗菌药物分析

立项前后我院围术期预防用抗菌药物情况调查分析Δ

实施抗菌药物专项整治活动对改善清洁手术围术期预防用药合理性的效果的Meta分析

Related Author

庞晓军陈英何显科骆萍

杨秀萍吴军吴峥嵘

史大宁秦利荣

林玉龙王琴芳李桂枝

刘　桦黄建权

王惠霞滕月鹏古殿杰

李金成张绍媚黄星尧

钟秀娟?扶玲?高燕灵?刘泽清?

Related Institution

No data

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰